Indo US Bio-Tech standalone net profit declines 46.47% in the March 2026 quarter
(01 Jun 2026)

Back
Net profit of Indo US Bio-Tech declined 46.47% to Rs 1.97 crore in the quarter ended March 2026 as against Rs 3.68 crore during the previous quarter ended March 2025. Sales declined 22.05% to Rs 26.02 crore in the quarter ended March 2026 as against Rs 33.38 crore during the previous quarter ended March 2025.

For the full year,net profit declined 19.36% to Rs 13.12 crore in the year ended March 2026 as against Rs 16.27 crore during the previous year ended March 2025. Sales rose 6.36% to Rs 110.44 crore in the year ended March 2026 as against Rs 103.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales26.0233.38 -22 110.44103.84 6
OPM %12.4113.69 -15.4018.24 -
PBDT2.654.43 -40 14.8217.63 -16
PBT2.383.87 -39 13.9216.53 -16
NP1.973.68 -46 13.1216.27 -19

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew